Literature DB >> 192098

Primary benign solid tumors of the liver.

J H Foster.   

Abstract

The benign solid primary tumors of the liver separate into three major groups: (1) the most common lesions--small, nodular tumors, often found incidentally with histologic features suggesting a reactive etiology, that never rupture or metastasize, that seem to grow most rapidly in children and pregnant women, and that are probably unrelated to birth control medication; (2) the less common adenomas that are purely epithelial, that most often occur in menstruating females, that often show necrosis and rupture, and that are closely associated with oral contraceptive agents; and (3) very rare tumors, usually mesenchymal, occurring solely in children. The therapeutic and prognostic implications of these tumors are defined based upon a study of 111 patients, all but one of whom have undergone resection.

Entities:  

Mesh:

Year:  1977        PMID: 192098     DOI: 10.1016/0002-9610(77)90144-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

Review 1.  Review of general surgery 1977.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1978-06       Impact factor: 2.401

2.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

3.  Benign liver tumors.

Authors:  J H Foster
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

4.  Focal nodular hyperplasia of the liver: results of treatment and options in management.

Authors:  J A Pain; A E Gimson; R Williams; E R Howard
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

5.  Hepatic incidentaloma: a modern problem.

Authors:  J M Little; J Kenny; M J Hollands
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

6.  Focal nodular hyperplasia of the liver.

Authors:  M Hisanaga; Y Nakajima; M Segawa; M Matsumoto; T Fukuoka; H Yabuuchi; H Nakano; H Maruyama; M Tsutsumi; Y Konishi
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.